Deborah H. Telman
CIK: 0001860008
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (32 total)
- May 18, 2026ATRC
AtriCure, Inc.
Award(A)Direct6.1K shares- - Nov 12, 2025GILD
GILEAD SCIENCES, INC.
Sale(S)Direct17.2K shares at avg. $124.00$2.1M - Nov 12, 2025GILD
GILEAD SCIENCES, INC.
Exercise(M)Direct17.2K shares at avg. $75.12$1.3M - Nov 12, 2025GILD
GILEAD SCIENCES, INC.
Exercise(M)Direct36K shares at avg. $60.75$2.2M - Nov 12, 2025GILD
GILEAD SCIENCES, INC.
Sale(S)Direct500 shares at avg. $122.90$61K - Nov 12, 2025GILD
GILEAD SCIENCES, INC.
Exercise(M)Direct500 shares at avg. $60.75$30K - Nov 12, 2025GILD
GILEAD SCIENCES, INC.
Sale(S)Direct36K shares at avg. $122.30$4.4M - Oct 25, 2025GILD
GILEAD SCIENCES, INC.
Tax Payment(F)Direct241 shares at avg. $120.94$29K - Oct 25, 2025GILD
GILEAD SCIENCES, INC.
Exercise(M)Direct515 shares- - Sep 10, 2025GILD
GILEAD SCIENCES, INC.
Tax Payment(F)Direct634 shares at avg. $115.25$73K - Sep 10, 2025GILD
GILEAD SCIENCES, INC.
Exercise(M)Direct1.3K shares- - Jul 25, 2025GILD
GILEAD SCIENCES, INC.
Tax Payment(F)Direct3.8K shares at avg. $116.20$444K - Jul 25, 2025GILD
GILEAD SCIENCES, INC.
Exercise(M)Direct514 shares- - Jul 25, 2025GILD
GILEAD SCIENCES, INC.
Exercise(M)Direct8.2K shares- - Jun 10, 2025GILD
GILEAD SCIENCES, INC.
Tax Payment(F)Direct430 shares at avg. $110.09$47K - Jun 10, 2025GILD
GILEAD SCIENCES, INC.
Exercise(M)Direct1.3K shares- - May 19, 2025ATRC
AtriCure, Inc.
Award(A)Direct5.4K shares- - Apr 25, 2025GILD
GILEAD SCIENCES, INC.
Tax Payment(F)Direct158 shares at avg. $103.17$16K - Apr 25, 2025GILD
GILEAD SCIENCES, INC.
Exercise(M)Direct514 shares- - Mar 10, 2025GILD
GILEAD SCIENCES, INC.
Award(A)DirectRestricted Stock Unit
7.7K shares- - Mar 10, 2025GILD
GILEAD SCIENCES, INC.
Exercise(M)Direct3.3K shares- - Mar 10, 2025GILD
GILEAD SCIENCES, INC.
Tax Payment(F)Direct1.1K shares at avg. $117.21$132K - Mar 10, 2025GILD
GILEAD SCIENCES, INC.
Award(A)DirectNon-qualified Stock Option (Right to Buy)
33.9K shares- - Feb 4, 2025GILD
GILEAD SCIENCES, INC.
Award(A)Direct12.4K shares- - Jan 25, 2025GILD
GILEAD SCIENCES, INC.
Exercise(M)Direct515 shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 18, 2026 |  ATRC AtriCure, Inc. | Award(A) | 6,144 | - | $0 | Direct |
| Nov 12, 2025 |  GILD GILEAD SCIENCES, INC. | Sale(S) | 17,181 | $124.00 | $2,130,444 | Direct |
| Nov 12, 2025 | GILD GILEAD SCIENCES, INC. | Exercise(M) | 17,181 | $75.12 | $1,290,637 | Direct |
| Nov 12, 2025 | GILD GILEAD SCIENCES, INC. | Exercise(M) | 35,965 | $60.75 | $2,184,874 | Direct |
| Nov 12, 2025 | GILD GILEAD SCIENCES, INC. | Sale(S) | 500 | $122.90 | $61,452 | Direct |
| Nov 12, 2025 | GILD GILEAD SCIENCES, INC. | Exercise(M) | 500 | $60.75 | $30,375 | Direct |
| Nov 12, 2025 | GILD GILEAD SCIENCES, INC. | Sale(S) | 35,965 | $122.30 | $4,398,591 | Direct |
| Oct 25, 2025 | GILD GILEAD SCIENCES, INC. | Tax Payment(F) | 241 | $120.94 | $29,147 | Direct |
| Oct 25, 2025 | GILD GILEAD SCIENCES, INC. | Exercise(M) | 515 | - | - | Direct |
| Sep 10, 2025 | GILD GILEAD SCIENCES, INC. | Tax Payment(F) | 634 | $115.25 | $73,069 | Direct |
| Sep 10, 2025 | GILD GILEAD SCIENCES, INC. | Exercise(M) | 1,315 | - | - | Direct |
| Jul 25, 2025 | GILD GILEAD SCIENCES, INC. | Tax Payment(F) | 3,823 | $116.20 | $444,233 | Direct |
| Jul 25, 2025 | GILD GILEAD SCIENCES, INC. | Exercise(M) | 514 | - | - | Direct |
| Jul 25, 2025 | GILD GILEAD SCIENCES, INC. | Exercise(M) | 8,229 | - | - | Direct |
| Jun 10, 2025 | GILD GILEAD SCIENCES, INC. | Tax Payment(F) | 430 | $110.09 | $47,339 | Direct |
| Jun 10, 2025 | GILD GILEAD SCIENCES, INC. | Exercise(M) | 1,313 | - | - | Direct |
| May 19, 2025 | ATRC AtriCure, Inc. | Award(A) | 5,401 | - | - | Direct |
| Apr 25, 2025 | GILD GILEAD SCIENCES, INC. | Tax Payment(F) | 158 | $103.17 | $16,301 | Direct |
| Apr 25, 2025 | GILD GILEAD SCIENCES, INC. | Exercise(M) | 514 | - | - | Direct |
| Mar 10, 2025 | GILD GILEAD SCIENCES, INC. | Award(A) Restricted Stock Unit | 7,680 | - | - | Direct |
| Mar 10, 2025 | GILD GILEAD SCIENCES, INC. | Exercise(M) | 3,343 | - | - | Direct |
| Mar 10, 2025 | GILD GILEAD SCIENCES, INC. | Tax Payment(F) | 1,130 | $117.21 | $132,447 | Direct |
| Mar 10, 2025 | GILD GILEAD SCIENCES, INC. | Award(A) Non-qualified Stock Option (Right to Buy) | 33,940 | - | - | Direct |
| Feb 4, 2025 | GILD GILEAD SCIENCES, INC. | Award(A) | 12,371 | - | - | Direct |
| Jan 25, 2025 | GILD GILEAD SCIENCES, INC. | Exercise(M) | 515 | - | $0 | Direct |
1-25 of 32 transactions
About Telman Deborah H
Telman Deborah H (SEC CIK 0001860008) files insider reports with the SEC as Director of AtriCure, Inc. (ATRC) and EVP, Corporate Affairs & GC of GILEAD SCIENCES, INC. (GILD).
Signal8 holds 14 ownership filings by Telman Deborah H, all Form 4s, filed between Sep 11, 2024 and May 20, 2026. Those filings report 32 transactions, from Sep 10, 2024 to May 18, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Telman Deborah H's filings is in FOSTER CITY, CA.
Recent filings by Telman Deborah H
- May 18, 2026: Grant or award of ATRC shares (Form 4, code A).
- Nov 12, 2025: Open-market sale of GILD shares (Form 4, code S).
- Nov 12, 2025: Option exercises of GILD shares (2 lines, Form 4, code M).
- Nov 12, 2025: Open-market sale of GILD shares (Form 4, code S).
- Nov 12, 2025: Option exercise of GILD shares (Form 4, code M).
Other insiders filing for AtriCure, Inc. (ATRC)
- Privitera Salvatore, Chief Technical Officer
- GROVES REGINA E, Director
- Dahlquist Karl S., Chief Legal Officer
- Prange Karen, Director
- Yuen Maggie, Director
- CARREL MICHAEL H, President, CEO, & Director